Revision as of 07:58, 19 December 2024 editPygos (talk | contribs)Extended confirmed users, New page reviewers2,304 editsNo edit summaryTag: Visual edit← Previous edit | Latest revision as of 07:41, 20 December 2024 edit undoGraeme Bartlett (talk | contribs)Administrators249,639 edits added Category:Anilines using HotCat | ||
(3 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
| image = Milverine.svg | | image = Milverine.svg | ||
| width = 250px | | width = 250px | ||
| caption = | | caption = <!-- Clinical data --> | ||
<!-- Clinical data --> | |||
| pronounce = | | pronounce = | ||
| tradename = | | tradename = | ||
Line 21: | Line 19: | ||
| class = | | class = | ||
| ATC_prefix = | | ATC_prefix = | ||
| ATC_suffix = | | ATC_suffix = <!-- Legal status --> | ||
⚫ | | legal_status = <!-- Pharmacokinetic data --> | ||
<!-- Legal status --> | |||
| legal_status = | |||
⚫ | <!-- Pharmacokinetic data --> | ||
| bioavailability = | | bioavailability = | ||
| protein_bound = | | protein_bound = | ||
Line 34: | Line 28: | ||
| elimination_half-life = | | elimination_half-life = | ||
| duration_of_action = | | duration_of_action = | ||
| excretion = | | excretion = <!-- Identifiers --> | ||
<!-- Identifiers --> | |||
| CAS_number = 75437-14-8 | | CAS_number = 75437-14-8 | ||
| CAS_supplemental = | | CAS_supplemental = | ||
Line 43: | Line 35: | ||
| DrugBank = | | DrugBank = | ||
| ChemSpiderID = 64284 | | ChemSpiderID = 64284 | ||
| UNII = | | UNII = 83B517YUVM | ||
| |
| ChEBI = 135196 | ||
| |
| ChEMBL = 2105255 | ||
⚫ | | synonyms = Fenprin, Fenpyramine, Miospasm | ||
⚫ | | |
||
| NIAID_ChemDB = | |||
| PDB_ligand = | |||
⚫ | | synonyms = Fenprin, Fenpyramine, Miospasm |
||
<!--Chemical data--> | <!--Chemical data-->| IUPAC_name = N-(3,3-diphenylpropyl)pyridin-4-amine | ||
| C = 20 | |||
| IUPAC_name = N-(3,3-diphenylpropyl)pyridin-4-amine | |||
| |
| H = 20 | ||
⚫ | | N = 2 | ||
| smiles = C1=CC=C(C=C1)C(CCNC2=CC=NC=C2)C3=CC=CC=C3 | | smiles = C1=CC=C(C=C1)C(CCNC2=CC=NC=C2)C3=CC=CC=C3 | ||
| StdInChI = 1S/C20H20N2/c1-3-7-17(8-4-1)20(18-9-5-2-6-10-18)13-16-22-19-11-14-21-15-12-19/h1-12,14-15,20H,13,16H2,(H,21,22) | | StdInChI = 1S/C20H20N2/c1-3-7-17(8-4-1)20(18-9-5-2-6-10-18)13-16-22-19-11-14-21-15-12-19/h1-12,14-15,20H,13,16H2,(H,21,22) | ||
| StdInChIKey = KMZHYAUKFHLFNY-UHFFFAOYSA-N | | StdInChIKey = KMZHYAUKFHLFNY-UHFFFAOYSA-N | ||
}} | }} | ||
'''Milverine''' is a ] (antispasmodic) agent that was developed in the latter half of the 20th century.<ref>Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID 5425728.</ref><ref>Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)</ref><ref>Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID 3770157.</ref> | '''Milverine (Fenprin, Fenpyramine, Miospasm)''' is a ] (antispasmodic) agent that was developed in the latter half of the 20th century.<ref>Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID 5425728.</ref><ref>Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)</ref><ref>Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID 3770157.</ref> | ||
The therapeutic use of fenpyramin as a ] and ] as well as ] and ] medicine was also identified.<ref>Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).</ref> | The therapeutic use of fenpyramin as a ] and ] as well as ] and ] medicine was also identified.<ref>Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).</ref> | ||
Line 67: | Line 57: | ||
The chemical synthesis of milverine was identified.<ref>Paolo Masi, Angela Monopoli, Adone Carlo Saravalle, Cesare Zio, DE3002909 (1980 to Italiana Schoum Spa).</ref> | The chemical synthesis of milverine was identified.<ref>Paolo Masi, Angela Monopoli, Adone Carlo Saravalle, Cesare Zio, DE3002909 (1980 to Italiana Schoum Spa).</ref> | ||
] | ] | ||
Conjugate soft addition of benzene to cinnamic acid (1) gives 3,3-diphenylpropionic acid (2). Halogenation with thionyl chloride gives 3,3-diphenylpropionyl chloride (3). Schotten-Baumann reaction with 4-aminopyridine (Fampridine) (4) gives 3,3-diphenyl-N-(4-pyridyl)propionamide (5). The last step involves reduction of the amide bond giving milverine (6), respectively. | ] of benzene to ] (1) gives 3,3-diphenylpropionic acid (2). Halogenation with thionyl chloride gives 3,3-diphenylpropionyl chloride (3). ] with 4-aminopyridine (Fampridine) (4) gives 3,3-diphenyl-N-(4-pyridyl)propionamide (5). The last step involves reduction of the ] giving milverine (6), respectively. | ||
== References == | == References == | ||
Line 75: | Line 65: | ||
] | ] | ||
] |
Latest revision as of 07:41, 20 December 2024
Pharmaceutical compoundClinical data | |
---|---|
Other names | Fenprin, Fenpyramine, Miospasm |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H20N2 |
Molar mass | 288.394 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Milverine (Fenprin, Fenpyramine, Miospasm) is a spasmolytic (antispasmodic) agent that was developed in the latter half of the 20th century.
The therapeutic use of fenpyramin as a platelet-antiaggregating and antithrombotic as well as vasodilating and antianginous medicine was also identified.
Milverine is a bifunctional molecule; one half of the molecule contains 3,3-Diphenylpropylamine and the other half of the molecule contains fampridine.
Synthesis
The chemical synthesis of milverine was identified.
Conjugate soft addition of benzene to cinnamic acid (1) gives 3,3-diphenylpropionic acid (2). Halogenation with thionyl chloride gives 3,3-diphenylpropionyl chloride (3). Schotten-Baumann reaction with 4-aminopyridine (Fampridine) (4) gives 3,3-diphenyl-N-(4-pyridyl)propionamide (5). The last step involves reduction of the amide bond giving milverine (6), respectively.
References
- Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID 5425728.
- Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)
- Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID 3770157.
- Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).
- Paolo Masi, Angela Monopoli, Adone Carlo Saravalle, Cesare Zio, DE3002909 (1980 to Italiana Schoum Spa).
Urologicals, including antispasmodics (G04B) | |
---|---|
Acidifiers | |
Urinary antispasmodics (primarily antimuscarinics) | |
Other urologicals |
|
Irritable bowel syndrome (IBS) | |
---|---|
Management | |
Related topics |